NasdaqHealth CareHealth Care ServicesS&P MidCap 400
$67.15
+1.29 (+1.96%)
Close of Nov 06, 2026 · end-of-day data
BTSG 8-K filings in 2026
Every material Form 8-K BrightSpring Health Services filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
BrightSpring Health Services reported third quarter 2026 net revenue of $4.21 billion and net income from continuing operations of $101 million, representing significant growth compared to the same period in 2025. Driven by strong performance across its pharmacy and provider businesses, the company also raised its full-year 2026 financial guidance for revenue and Adjusted EBITDA.
Net revenue for the third quarter of 2026 reached $4,213 million, up 26.4% from $3,334 million in the third quarter of 2025.
Adjusted EBITDA for the third quarter of 2026 increased 42.0% to $228 million compared to $160 million in the prior-year period.
Full-year 2026 revenue guidance was increased to a range of $15,900 million to $16,125 million, and Adjusted EBITDA guidance was raised to $850 million to $860 million.
BrightSpring reported second quarter 2026 net revenue of $3.87 billion, up 23.0% from a year earlier, and net income of $87 million compared with $9 million in the second quarter of 2025. The company also raised its full-year 2026 revenue and Adjusted EBITDA guidance, which excludes the Community Living business it divested on March 30, 2026. For shareholders, the quarter shows higher revenue and profit and a higher full-year outlook.
Q2 2026 net revenue of $3,873 million, up 23.0% from $3,148 million; gross profit of $493 million, up 31.5%
Net income of $87 million vs. $9 million in Q2 2025; diluted EPS of $0.38 vs. $0.13 attributable to common shareholders
Full-year 2026 revenue guidance raised to $15,100 million to $15,425 million; Adjusted EBITDA guidance raised to $820 million to $845 million
Leverage fell to 2.15x at June 30, 2026, from 2.27x at March 31, 2026, after a $300.0 million First Lien Facility paydown
BrightSpring Health Services appointed Dr. Nigam H. Shah as a Class III director on June 11, 2026, increasing the Board from seven to eight members. Dr. Shah also joined the Quality and Compliance Committee, and the filing discloses no related-party transactions with him.
Board increased from seven to eight members on June 11, 2026, to fill the new seat with Dr. Shah
Dr. Shah is a Stanford University professor and Chief Data Scientist at Stanford Healthcare
Dr. Shah will receive director compensation under company policy and an indemnification agreement is planned
Press release dated June 12, 2026 furnished as Exhibit 99.1
Selling stockholders, including KKR Phoenix Aggregator L.P. and management, sold 14,999,771 BrightSpring common shares in an underwritten offering priced at $58.75 per share, with closing on June 5, 2026. The company did not receive offering proceeds, except cash from option exercises by management sellers, but it separately bought back 1,026,465 shares from the underwriter, which shareholders should note as a change in the share count and float.
Offering: 14,999,771 shares of common stock sold by selling stockholders at $58.75 per share, under a June 3, 2026 underwriting agreement with Goldman Sachs & Co. LLC
Company repurchase: BrightSpring bought 1,026,465 shares from the underwriter as part of the offering; the underwriter received no fees on these shares
Proceeds: the company received no offering proceeds beyond cash from management stock option exercises
Filing: offering made under a Form S-3ASR shelf registration filed June 10, 2025; closing occurred June 5, 2026
BrightSpring reported first-quarter 2026 net revenue of $3,614 million, up 25.6%, and net income from continuing operations of $74 million, compared with $9 million a year earlier. It increased full-year 2026 revenue guidance to $14,725 million to $15,225 million and Adjusted EBITDA guidance to $795 million to $825 million, which excludes the divested Community Living business.
Q1 2026 net revenue of $3,614 million, up 25.6% from $2,878 million in Q1 2025
Net income from continuing operations of $74 million versus $9 million; Adjusted EBITDA of $190 million, up 44.8%
Full-year 2026 Adjusted EBITDA guidance raised to $795 million to $825 million
Community Living divestiture to Sevita closed March 30, 2026, with a $31.2 million gain on sale, net of tax, in discontinued operations
BrightSpring Health Services completed the sale of its Community Living business to National Mentor Holdings (Sevita) on March 30, 2026, for $835 million in cash, subject to customary adjustments. The filing also says the company expects to repay $425 million of its first lien term loan after closing, and that Community Living president Robert Barnes resigned effective at closing.
Aggregate cash consideration at closing: $835 million, subject to working capital and other customary adjustments
Closing date: March 30, 2026; the company issued a press release on March 31, 2026
Expected repayment of $425 million of the first lien term loan after closing
Robert Barnes resigned as President, ResCare Community Living; accelerated vesting of 15,540 RSUs and 5,640 stock options, with no severance
BrightSpring Health Services agreed on March 2, 2026 to a secondary offering of 20,000,000 common shares at $41.15 per share, all sold by selling stockholders including KKR Phoenix Aggregator L.P. The offering closed March 4, 2026, and the company did not receive offering proceeds, but it repurchased 1,464,807 shares from the underwriter, which the filing says carried no underwriting fees.
Offering: 20,000,000 common shares sold by selling stockholders at $41.15 per share, led by Goldman Sachs & Co. LLC as underwriter
Company received no offering proceeds, apart from cash from management stock option exercises
Company repurchased 1,464,807 shares from the underwriter as part of the offering, with no underwriting fees
Offering was made under an automatic shelf registration filed June 10, 2025; closing occurred March 4, 2026
BrightSpring reported fourth-quarter 2025 revenue of $3,551 million, up 29.3%, and net income from continuing operations of $49.6 million, up from $4.3 million a year earlier. The company also initiated full-year 2026 revenue guidance of $14,450 million to $15,000 million and Adjusted EBITDA guidance of $760 million to $790 million, both excluding the Community Living business.
Q4 2025 Adjusted EBITDA was $184 million, up 40.7% from $130 million; full-year 2025 Adjusted EBITDA was $618 million, up 34.2%.
Full-year 2025 net income from continuing operations was $104.8 million, compared with a net loss of $68.9 million in 2024.
Leverage fell to 2.99x at December 31, 2025, from 4.16x a year earlier.
The Community Living divestiture to Sevita is expected to close by the end of the first quarter of 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every BrightSpring Health Services filing is on SEC EDGAR ↗. 8-K briefs of other companies →